ISRADIPINE Side Effects

6654290-5 |
on Mar 22, 2010 Male patient from UNITED STATES , 57 years of age, was treated with Isradipine (View Usage). . Isradipine dosage: Unk. During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ETHANOL (View Ethanol Review and Ethanol Label ).

6188136-9 | Nausea
Patient was taking Isradipine (View Usage). Patient had the following side effects: nausea (What is nausea?) on Nov 17, 2008 from UNITED STATES Additional patient health information: Female patient , 56 years of age, was diagnosed with hypertension and. Isradipine dosage: 5mg Twice Per Day. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), CLARINEX (View Clarinex Review and Clarinex Label ), DURAXIL (View Duraxil Review and Duraxil Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), IMITREX (View Imitrex Review and Imitrex Label ), VITAMINS (View Vitamins Review and Vitamins Label ), XANAX (View Xanax Review and Xanax Label ).

6098852-5 | Bronchitis, Diarrhoea, Gout, Renal Failure Acute, Thrombotic Microangiopathy, Vomiting
Adverse event was reported on Feb 27, 2009 by a Male patient taking Isradipine (View Usage) (Dosage: 2.6mg Per Day) was diagnosed with heart transplant (What is heart transplant?) and. Location: FRANCE , 63 years of age, After Isradipine was administered, patient had the following side effects: bronchitis (What is bronchitis?), diarrhoea, gout (What is gout?), renal failure acute, thrombotic microangiopathy, vomiting. During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), PROGRAF (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), SOLUPRED (View Solupred Review and Solupred Label ), EUPHYLLINE (View Euphylline Review and Euphylline Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

5822217-1 | Depression, Muscle Spasms, Myalgia, Suicidal Ideation
on Jul 23, 2008 Female patient from UNITED STATES , weighting 110.0 lb, was diagnosed with hypertension and was treated with Isradipine (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), muscle spasms, myalgia, suicidal ideation. Isradipine dosage: 10mg Qam Po, ?3 Weeks. Patient was hospitalized.


5806771-1 | Blood Pressure Fluctuation, Blood Pressure Increased, Burning Sensation, No Therapeutic Response, Parosmia, Poisoning
on Jul 09, 2008 Male patient from UNITED STATES , 64 years of age, weighting 162.0 lb, was diagnosed with hypertension and was treated with Isradipine (View Usage). Patient had the following side effects: blood pressure fluctuation, blood pressure increased, burning sensation, no therapeutic response, parosmia, poisoning (What is poisoning?). Isradipine dosage: 2.5mg 2x/day Po. During the same period patient was treated with DYNACIRC (5 Mg 1x Po,) (View Dynacirc Review and Dynacirc Label ).

5786203-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Biliary Tract Disorder, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Gamma-glutamyltransferase Increased, Hepatic Fibrosis, Hepatic Steatosis, Liver Function Test Abnormal
Patient was taking Isradipine (View Usage). After Isradipine was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, biliary tract disorder, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatic fibrosis, hepatic steatosis, liver function test abnormal on Jun 20, 2008 from FRANCE Additional patient health information: Female patient , 57 years of age, was diagnosed with liver transplant (What is liver transplant?) and. Isradipine dosage: 2.5mg Per Day. During the same period patient was treated with NEORAL (200mg Per Day) (View Neoral Review and Neoral Label ), COPEGUS (View Copegus Review and Copegus Label ), PEGASYS (180mg Weekly) (View Pegasys Review and Pegasys Label ), OMEPRAZOLE (20mg Per Day) (View Omeprazole Review and Omeprazole Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), COZAAR (50mg Per Day) (View Cozaar Review and Cozaar Label ), LASIX (40mg Per Day) (View Lasix Review and Lasix Label ).

5663428-8 | Anaemia, Blood Folate Decreased, Blood Immunoglobulin E Increased, Echography Abnormal, Hyperthyroidism, Interstitial Lung Disease, Pulmonary Fibrosis, Weight Decreased
Adverse event was reported on Mar 02, 2008 by a Male patient taking Isradipine (View Usage) (Dosage: 5 Mg;po) was diagnosed with hypertension and. Location: CHILE , 78 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, blood folate decreased, blood immunoglobulin e increased, echography abnormal, hyperthyroidism, interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?), weight decreased. During the same period patient was treated with AMIODARONE HCL (Po) (View Amiodarone Hcl Review and Amiodarone Hcl Label ), HYTACAND (BLOPRESS PLUS) (Po) (View Hytacand (blopress Plus) Review and Hytacand (blopress Plus) Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), NEO MERCAZOLE TAB (View Neo-mercazole Tab Review and Neo-mercazole Tab Label ), CARBIMAZOLE (View Carbimazole Review and Carbimazole Label ), PROPYLTHIOURACIL (View Propylthiouracil Review and Propylthiouracil Label ), ERTHROCYTE CONCENTRATE (View Erthrocyte Concentrate Review and Erthrocyte Concentrate Label ).

5605693-9 | Hepatic Fibrosis, Hepatic Steatosis
on Jan 16, 2008 Female patient from SWITZERLAND , 57 years of age, was diagnosed with liver transplant (What is liver transplant?) and was treated with Isradipine (View Usage). Patient had the following side effects: hepatic fibrosis, hepatic steatosis. Isradipine dosage: 2.5 Mg; Qd; Po. During the same period patient was treated with NEORAL (200 Mg; Qd; Po) (View Neoral Review and Neoral Label ), COPEGUS (6 Df; Qd; Po) (View Copegus Review and Copegus Label ), PEGINTERFERON ALFA 2A (PEGINTERFERON ALFA 2A) (180 Mg; Qw; Sc) (View Peginterferon Alfa-2a (peginterferon Alfa-2a) Review and Peginterferon Alfa-2a (peginterferon Alfa-2a) Label ), OMEPRAZOLE (20 Mg; Qd; Po) (View Omeprazole Review and Omeprazole Label ), POTASSIUM CHLORIDE (1 Df; Qd; Po) (View Potassium Chloride Review and Potassium Chloride Label ), COZAAR (50 Mg; Qd; Po) (View Cozaar Review and Cozaar Label ), FUROSEMIDE (40 Mg; Qd; Po) (View Furosemide Review and Furosemide Label ).

5601145-0 | Acute Pulmonary Oedema, Condition Aggravated, Cough, Hypertension, Left Ventricular Failure, Post Procedural Complication
on Jan 10, 2008 Male patient from SWITZERLAND , child 3 years of age, weighting 24.30 lb, was diagnosed with hypertension and was treated with Isradipine (View Usage). After Isradipine was administered, patient had the following side effects: acute pulmonary oedema, condition aggravated, cough, hypertension, left ventricular failure, post procedural complication. Isradipine dosage: ;po. During the same period patient was treated with NICARDIPINE HCL (1 Mg;qh;iv) (View Nicardipine Hcl Review and Nicardipine Hcl Label ), CORGARD (13 Mg;qd;po) (View Corgard Review and Corgard Label ). Patient was hospitalized.

5376548-2 | Agitation, Nervousness
Patient was taking Isradipine (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, nervousness on Jun 19, 2007 from SWITZERLAND Additional patient health information: Male patient , 69 years of age, weighting 154.4 lb, was diagnosed with hypertension and. Isradipine dosage: 2.5 Mg;po.

5331815-3 | Dermatitis Allergic
Adverse event was reported on May 11, 2007 by a Male patient taking Isradipine (View Usage) (Dosage: 5 Mg;qd;) was diagnosed with hypertension and. Location: SWITZERLAND , 77 years of age, Patient had the following side effects: dermatitis allergic. During the same period patient was treated with ANOPYRIN (View Anopyrin Review and Anopyrin Label ), ANDROCUR (View Androcur Review and Androcur Label ), DOXAZOSIIN (View Doxazosiin Review and Doxazosiin Label ). Patient was hospitalized.

5186532-X | Decreased Appetite, Fluid Intake Reduced, Gastric Ulcer Perforation, Haemodialysis, Hypoglycaemia, Infection, Lactic Acidosis, Loss Of Consciousness, Pharyngitis
on Nov 28, 2006 Female patient from SWITZERLAND , 62 years of age, was diagnosed with hypertension, diabetes mellitus, infection (What is infection?), upper respiratory tract infection and was treated with Isradipine (View Usage). After Isradipine was administered, patient had the following side effects: decreased appetite, fluid intake reduced, gastric ulcer perforation, haemodialysis, hypoglycaemia, infection (What is infection?), lactic acidosis, loss of consciousness, pharyngitis. Isradipine dosage: 5 Mg; Qd; Po. During the same period patient was treated with NISISCO (CO DIOVAN) (1 Df; Qd; Po) (View Nisisco (co-diovan) Review and Nisisco (co-diovan) Label ), METFORMIN HCL (1 Gm; Qd; Po) (View Metformin Hcl Review and Metformin Hcl Label ), KETOPROFEN (100 Mg; Qd; Im) (View Ketoprofen Review and Ketoprofen Label ), DIAMICRON (GLICLAZIDE) (30 MG) (4 Df; Qd; Po) (View Diamicron (gliclazide) (30 Mg) Review and Diamicron (gliclazide) (30 Mg) Label ), ROCEPHINE /00672201/ (CEFTRIAXONE) (1 Gm; Qd; Im) (View Rocephine /00672201/ (ceftriaxone) Review and Rocephine /00672201/ (ceftriaxone) Label ), LESCOL /01224501/ (View Lescol /01224501/ Review and Lescol /01224501/ Label ). Patient was hospitalized.

5145556-9 | Systemic Lupus Erythematosus
on Oct 24, 2006 Female patient from SWITZERLAND , 69 years of age, weighting 132.3 lb, was treated with Isradipine (View Usage). Patient experienced the following unwanted or unexpected effects: systemic lupus erythematosus. Isradipine dosage: 5 Mg; Qd; Po. During the same period patient was treated with TEGRETOL (400 Mg; Bid; Po) (View Tegretol Review and Tegretol Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ARICEPT (View Aricept Review and Aricept Label ). Patient was hospitalized.

5081932-0 | Asthenia, Bronchial Disorder, Cough, Eosinophilia, Hypocapnia, Hypoxia, Inflammation, Interstitial Lung Disease, Metaplasia
Patient was taking Isradipine (View Usage). Patient had the following side effects: asthenia, bronchial disorder, cough, eosinophilia, hypocapnia, hypoxia, inflammation, interstitial lung disease, metaplasia on Aug 04, 2006 from FRANCE Additional patient health information: Male patient , 81 years of age, was diagnosed with myocardial ischaemia and. Isradipine dosage: 2.5 Mg;qd;po. During the same period patient was treated with ATENOLOL (25 Mg;qd;po) (View Atenolol Review and Atenolol Label ), PLAVIX (75 Mg;qd;po) (View Plavix Review and Plavix Label ), ALLOPURINOL (200 Mg;qd;po) (View Allopurinol Review and Allopurinol Label ), SIMVASTATIN (40 Mg;qd;po) (View Simvastatin Review and Simvastatin Label ), ASPIRIN (160 Mg;qd;po) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5029038-0 | Asthenia, Cough, Pulmonary Fibrosis
Adverse event was reported on Jun 06, 2006 by a Male patient taking Isradipine (View Usage) (Dosage: 2.5 Mg; Po) was diagnosed with myocardial ischaemia and. Location: UNITED STATES , 81 years of age, After Isradipine was administered, patient had the following side effects: asthenia, cough, pulmonary fibrosis (What is pulmonary fibrosis?). During the same period patient was treated with ATENOLOL (25 Mg; Qd) (View Atenolol Review and Atenolol Label ), PLAVIX (75 Mg; Qd) (View Plavix Review and Plavix Label ), ALLOPURINOL (200 Mg; Qd) (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

5022223-3 | Headache, Oedema Peripheral
on Jun 23, 2005 Female patient from CZECH REPUBLIC , 61 years of age, was diagnosed with hypertension and was treated with Isradipine (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), oedema peripheral. Isradipine dosage: 5 Mg;qd;po. During the same period patient was treated with FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ).

4952917-7 | Hydrocele
on Mar 08, 2006 Male patient from FRANCE , 58 years of age, weighting 209.5 lb, was diagnosed with hypertension and was treated with Isradipine (View Usage). Patient had the following side effects: hydrocele. Isradipine dosage: 2.5 Mg;qd;po.

4805492-1 | Pruritus, Rash
Patient was taking Isradipine (View Usage). After Isradipine was administered, patient had the following side effects: pruritus, rash (What is rash?) on Oct 07, 2005 from CZECH REPUBLIC Additional patient health information: Female patient , 82 years of age, . Isradipine dosage: 5 Mg; Qd; Po.

4656407-0 | Asthenia, Atrial Flutter, Bundle Branch Block Right, Diarrhoea, Dysarthria, Hepatic Encephalopathy, Hepatic Failure, Hepatic Necrosis
Adverse event was reported on Apr 22, 2005 by a Female patient taking Isradipine (View Usage) (Dosage: 5 Mg; Qd; Po) was diagnosed with hypertension, pneumonia (What is pneumonia?) and. Location: , 58 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, atrial flutter, bundle branch block right, diarrhoea, dysarthria, hepatic encephalopathy, hepatic failure, hepatic necrosis. During the same period patient was treated with CLARITHROMYCIN (500 Mg; Qd) (View Clarithromycin Review and Clarithromycin Label ), ACETYLCYSTEINE (View Acetylcysteine Review and Acetylcysteine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CHLOROQUINE PHOSPHATE (View Chloroquine Phosphate Review and Chloroquine Phosphate Label ). Patient was hospitalized.